New blood thinner could make heart bypass safer during surgery
NCT ID NCT07514962
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study is testing whether giving the blood thinner cangrelor through a vein during minimally invasive heart bypass surgery is safe and practical. The goal is to prevent dangerous blood clots while the patient is on the operating table. Researchers will compare 30 patients receiving cangrelor during surgery to similar patients from the past who received standard care with aspirin. The main focus is on whether cangrelor increases the risk of serious bleeding.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- cangrelor (a fast-acting blood thinner given through a vein)
- What this could lead to
- If successful, this could make minimally invasive heart bypass surgery safer by preventing blood clots during the procedure without increasing bleeding complications.
- What could go wrong
- This is a small, early-phase study with only 30 participants, so results may not apply to all patients. There is still a risk of bleeding or other complications despite careful monitoring.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANTIPLATELET THERAPY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Istituto Cardiocentro Ticino
RECRUITINGLugano, Ch/ti, 6900, Switzerland
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Software-Guided heart procedures: a new standard for coronary care?
- Heart patients may stay active longer with coach calls and group support
- Sitting less could be a lifeline for frail hearts – a new trial tests a simple program
- Can balloon timing make or break heart artery success?
- Can we predict which heart aneurysms will grow?
- Can a higher dose of adenosine sharpen heart scans?